Utah Medical Products (UTMD) Earnings Analysis
Utah Medical Products (UTMD) has no confirmed upcoming earnings date. Trailing P/E 20.97.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does UTMD next report earnings?
No confirmed upcoming earnings date is currently scheduled for UTMD. This page updates as the calendar is published.
UTMD earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-07-23 | 0.84 USD | n/a | n/a | n/a |
| 2026-04-23 | 0.82 USD | n/a | n/a | n/a |
| 2026-01-29 | 0.8 USD | n/a | n/a | n/a |
| 2025-10-23 | 0.82 USD | n/a | n/a | n/a |
| 2025-07-24 | 0.94 USD | n/a | n/a | n/a |
| 2024-07-25 | 0.98 USD | n/a | n/a | n/a |
UTMD valuation and analyst view
| Trailing P/E | 20.97 |
|---|---|
| Trailing EPS | 3.406 USD |
| Price / book | 1.83 |
| Dividend yield | 1.78% |
| Market cap | 0.22B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Utah Medical Products (UTMD)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for UTMD. This page updates as the calendar is published.
Did UTMD beat earnings last quarter?
Consensus estimate data was not available for UTMD's 2026-07-23 report.
What is UTMD's current P/E ratio and EPS?
UTMD trades at a trailing P/E of 20.97 on trailing EPS of 3.4059654631083203 USD.
What do analysts rate UTMD?
UTMD has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.